期刊文献+

左心耳封堵术(LAAC)用于接受其他心脏介入手术治疗的心房纤颤(房颤)患者的安全性及可行性分析 被引量:1

Safety and Feasibility of Left Atrial Appendage Occlusion(LAAC) in Patients with Atrial Fibrillation(AF) Undergoing Other Cardiac Interventional Procedures
下载PDF
导出
摘要 目的分析左心耳封堵术(LAAC)用于接受其他心脏介入治疗的心房纤颤(房颤)患者的安全性及可行性。方法方便选取2016年1月-2018年6月期间该院接收的18例心房纤颤患者作为研究对象,所有患者均在进行左心耳封堵术进行治疗时,接受其他心脏介入手术治疗,观察并分析患者经过治疗后的临床效果和安全性。结果 18例患者左心耳封堵术均手术成功,其中左心耳最大直径为17~29 cm,封堵器直径为27~35 mm,封堵器压缩比为16.5%~32.9%,封堵器与推送杆完全解离后仅发现1例患者封堵器附近出现残余分流(3 mm),剩余17例均未出现残余分流;同时,经过术后随访,18例患者均未出现任何出血情况和动脉栓塞事件。结论心房纤颤患者在接受导管主动脉瓣置换术、经皮冠状动脉介入以及心导管射频消融术心脏介入手术治疗时,予以左心耳封堵术,能够有效改善患者临床症状,控制患者术后出血与动脉栓塞等不良事件的发生,具有可行性与安全性。 Objective To analyze the safety and feasibility of left atrial appendage occlusion(LAAC) in patients with atrial fibrillation(AF) undergoing other cardiac interventions. Methods Eighteen patients with atrial fibrillation received in the hospital from January 2016 to June 2018 were conveniently selected as the study subjects. All patients received other interventional cardiac surgery during the treatment of left atrial appendage occlusion. The clinical effect and safety of the patients after treatment were observed and analyzed. Results All 18 patients were successfully operated. The maximum diameter of left atrial appendage was 17-29 cm, the diameter of occluder was 27-35 mm, and the compression ratio of occluder was 16.5%-32.9%. Only one patient had residual shunt(3 mm) near the occluder after the occluder and push rod were completely removed. No residual shunt was found in the remaining 17 patients. At the same time, after follow-up, no bleeding or arterial embolism occurred in 18 patients. Conclusion The left atrial appendage occlusion in patients with atrial fibrillation undergoing catheter aortic valve replacement, percutaneous coronary intervention and cardiac catheter radiofrequency ablation can effectively improve the clinical symptoms of patients and control the occur rence of adverse events such as bleeding and arterial embolism.
作者 陆宏 陶杰 罗雪婷 黄宏波 LU Hong;TAO Jie;LUO Xue-ting;HUANG Hong-bo(Department of Cardiovascular Surgery,the First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan Province,650032 China)
出处 《中外医疗》 2020年第10期45-47,共3页 China & Foreign Medical Treatment
关键词 左心耳封堵术 心脏介入手术 心房纤颤 安全性 可行性 Left atrial appendage occlusion Cardiac interventional surgery Atrial fibrillation Safety Feasibility
  • 相关文献

参考文献6

二级参考文献43

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2Society of Cardiology, Chinese Medical Association.Retrospective investigation of hospitalized patients with atrial fibrillation in China's Mainland[J].Chinese Medical Journal,2004,17(12):1763-1767. 被引量:23
  • 3Tilz R R,Rillig A,Thum A M,etal. Catheter ablation of long- standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy[J]. J Am Coll Cardi- ol, 2012,60(19) :1921-1929.
  • 4Mcbride R. Warfarin versus aspirin for prevention of thrombo- embolism in atrial fibrillation: stroke prevention in atrial fibril- lation Ⅱstudy[J]. Lancet, 1994,343(8899):687-691.
  • 5Comes T,Mamdani M M,Holbrook A M,et al. Rates ofhem- orrhage during warfarin therapy for atrial fibrillation [J]. CMAJ, 2013,185 :E121-127.
  • 6Reddy V Y, Doshi S K,Sievert H, etal. Percutaneous left at- rial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2. 3-year follow-up of the PROTECT AF (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial[J].Circulation, 201a, 127(6) : 720-729.
  • 7Villani G Q,Piepoli P E,VilIani P E,et al. Anticoagulationin atrial fibrillation, what is certain and what is to come[J]. Eur Hcart J, 2003(Suppl) :45-50.
  • 8Odell J A,Blackshear J L,Davies E,et al. Thoraeoseopic oblit- eration of the left atrial appendage~ potential for stroke redue tion[J]? Ann Thorac Surg , 1996,61,565-569.
  • 9Reddy V Y,Mobius Winkler S,Miller M A, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral antieoagulation the ASAP study (ASA plavix feasibility study with watchman left atrial ap- pendage closure technology) [J]. J Am Col! Cardiol, 2013, 61(25) :2551-2556.
  • 10Holmes D R, Kar S, Price M J, et al. Prospective randomized evaluation of the watchman le{t atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J].J Am Coll Cardio, 2014, 64(1) :1-12.

共引文献32

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部